Welcome to our dedicated page for Lear SEC filings (Ticker: LEA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating when Lear Corporation shifts metal prices into seating margins or funds a new E-Systems plant often means sifting through hundreds of dense pages. With two globally sourced segments and intricate supply agreements, Lear’s SEC disclosures rival an engineering schematic—precise, vital, and hard to decode.
Stock Titan turns that schematic into a clear roadmap. Our AI-powered summaries make the phrase “Lear annual report 10-K simplified” a reality, extracting segment profitability and commodity hedges in plain English. Every “Lear quarterly earnings report 10-Q filing” is parsed for backlog changes, while “Lear 8-K material events explained” flags sudden plant launches or labor actions. Need speed? Real-time alerts on “Lear Form 4 insider transactions real-time” show when executives buy or sell the moment EDGAR posts.
Answer the exact questions professionals Google every quarter:
- “Lear proxy statement executive compensation” — compare CEO pay to peer suppliers.
- “Lear insider trading Form 4 transactions” — track buying patterns before model launches.
- “Lear earnings report filing analysis” — view AI-generated trends across Seating and E-Systems.
Whether you type “Lear SEC filings explained simply” or “understanding Lear SEC documents with AI,” our platform delivers. Comprehensive coverage of 10-K, 10-Q, 8-K, S-8, and “Lear executive stock transactions Form 4” arrives seconds after filing, complete with expert context and downloadable tables. Save hours, spot risks early, and make confident decisions with always-fresh data and clear analysis.
Insider sale disclosed on Form 4 for LEA. Frank C. Orsini, listed as EVP and President, Seating and a director, sold 8,500 shares of Lear Corporation common stock on 08/26/2025 at a weighted average price of $110.619 per share. After the reported sale, the filing shows Orsini beneficially owned 14,785 shares. The filer notes the reported price is a weighted average from multiple trades ranging $110.335 to $110.85 and offers to provide volume-by-price details on request. The Form 4 was signed by an attorney-in-fact on 08/27/2025.
Lear Corporation (LEA) Form 144 filing summary: The filing notifies a proposed sale of 8,500 shares of common stock through Fidelity Brokerage Services LLC (900 Salem Street, Smithfield, RI) on or about 08/26/2025. The aggregate market value of the proposed sale is reported as $940,262.04 and the number of shares outstanding is listed as 53,206,093. The securities were acquired via restricted stock vesting on three dates: 1,376 shares on 01/02/2023, 6,433 shares on 02/08/2023, and 691 shares on 01/04/2024, with payment characterized as compensation. The filer reports no securities sold in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information and contains the required signature and legal warnings.
Lear Corp (LEA) Form 4 filing: SVP & CFO Jason M. Cardew executed two open-market sales on 29-Jul-2025 totaling 5,000 common shares.
- Sold 3,171 shares at $99.50
- Sold 1,829 shares at $96.694
Following the transactions, Cardew directly owns 20,244 shares, down from 25,244. No derivative securities were reported and no Rule 10b5-1 plan box was checked. Estimated aggregate proceeds are roughly $0.49 million. The sale represents a modest reduction of the insider’s position while leaving a meaningful remaining stake.
Form 4 filing for Lear Corp. (LEA) discloses that President & CEO Raymond E. Scott, who is also a director, sold a total of 5,000 common shares on 29 Jul 2025.
- Weighted‐average sale prices: $96.5789 for 4,354 shares, $97.8828 for 504 shares, and $98.8444 for 142 shares (detailed price ranges provided).
- Gross proceeds ≈ $485 k.
- Following the transactions, Scott directly owns 38,729 shares, down roughly 11% from 43,729.
No derivative transactions were reported. The filing was signed by attorney-in-fact Jacqlyn Waite on 31 Jul 2025.
While the sale is modest relative to Lear’s market capitalization and Scott retains a sizable stake, investors often monitor CEO sales for potential sentiment signals.
On 24 Jul 2025 Lear Corporation (LEA) entered into a Second Amended & Restated Credit Agreement that extends the maturity of its US$2.0 billion unsecured revolving credit facility to 24 Jul 2030. JPMorgan Chase acts as administrative agent; Bank of America, BNP Paribas, Citibank and HSBC serve as syndication agents.
Borrowings will float over (i) Term Benchmark, Central Bank or Risk-Free Rates or (ii) ABR/Canadian Prime. As of 28 Jun 2025 the applicable pricing grid is 0.925%-1.450% for benchmark-based loans and 0.000%-0.450% for ABR/Prime loans. A quarterly facility fee of 0.075%-0.20% on total commitments applies.
The facility carries customary covenants, including a maximum leverage ratio, limits on fundamental changes, indebtedness and liens. Management states the company is in full covenant compliance as of the signing date. No other financial data or earnings information were provided.
Form 144 filing reports a proposed sale of 5,000 common shares on the NYSE with an aggregate market value of $492,367.64. The transaction is expected to occur on or about 29 July 2025. Relative to the 53,206,093 shares outstanding, the sale represents roughly 0.009 % of the float, indicating an immaterial level of potential selling pressure.
The securities were acquired through a series of restricted-stock vesting events between January 2020 and January 2023. No sales have been made by the filer during the past three months. By signing the notice, the filer attests to possessing no undisclosed material adverse information about the issuer.
Key details such as the seller’s identity and relationship to the issuer are not disclosed in the excerpt provided.
Lear Corporation (LEA) – Form 144 filing: An unidentified affiliate plans to sell up to 5,000 common shares, equal to roughly 0.009% of the 53.2 million shares outstanding. Using an implied price of $99.50, the aggregate market value of the proposed sale is $497,500. The shares were acquired through restricted-stock vesting on 02 Feb 2024 as compensation. The filer intends to execute the sale through Fidelity Brokerage Services on or about 29 Jul 2025, with the NYSE listed as the trading venue.
The notice states that the seller attests to having no undisclosed material adverse information about Lear and affirms compliance with Rule 144. No other sales by the filer occurred during the past three months, and no non-cash consideration was involved in acquiring the shares.
FAQ
What is the current stock price of Lear (LEA)?
What is the market cap of Lear (LEA)?
